Caris Life Sciences Inc. (CAI)
CAI trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$29.53
-0.54% on the day
Market cap
$8.3B
Mid cap
Revenue · 2025
$812.0M
+97.0% on 2024
Net income · 2025
-$68.1M
-8.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | CAI on Nasdaq |
| Sector | Health Care |
| Industry | Medical Specialities |
| Country | United States |
| IPO year | 2025 |
| SEC CIK | 0002019410 |
| SEC industry code | Services-Medical Laboratories |
| Incorporated in | TX |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $812.0M |
| Net income | -$68.1M |
| Operating income | $45.1M |
| Net margin | -8.4% |
| Operating margin | 5.6% |
| Revenue growth | +97.0% |
| Cash | $796.3M |
| Total assets | $1.1B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 10.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2025-06-20 |
| Latest annual report | 10-K | 2026-03-03 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-09-14 |
| Latest proxy | DEFA14A | 2026-04-23 |
Source: SEC EDGAR submissions feed, 131 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +11.7% |
| 1 month | +6.2% |
| 3 months | +83.7% |
| Year to date | +12.2% |
| 1 year | +0.1% |
| From 52-week high | -6.2% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical Specialities
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| HSIC | Henry Schein Inc. | $85.03 | +0.95% | $9.5B |
| OSCR | Oscar Health Inc. | $33.79 | -0.65% | $10.4B |
| MOH | Molina Healthcare Inc | $209.50 | +2.52% | $10.9B |
| GRAL | GRAIL Inc. Common Stock | $140.35 | +2.17% | $6.3B |
| RDNT | RadNet Inc. | $71.51 | +0.03% | $5.6B |
| CON | Concentra Group Holdings Parent Inc. | $37.54 | 0.00% | $4.8B |
| BLLN | BillionToOne Inc. | $94.44 | +1.47% | $4.5B |
| VCYT | Veracyte Inc. | $43.11 | -2.07% | $3.5B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier